• Protocols

• EA2192

  OPEN TO ACCRUAL

  APOLLO: PII Adjuvant Olaparib vs Placebo for Resected Pancreatic Cancer with BRCA1/2 or PALB2
  
  

• NCI10464

  OPEN TO ACCRUAL

  Ph1 Olaparib in Combo with durvalumab & radiation following 1st line chemo locally adv unresec panc